Resources

This brief outlines the current need for increased efforts to strengthen global health security following recent infectious disease and pandemic threats to human health, as well as America’s leading role in spearheading it.

This report presents the methods and findings from laboratory testing of two energy harvesting control (EHC) prototypes with three different Performance, Quality and Safety prequalified solar direct–drive refrigerators from three different manufacturers. The primary goals of the testing were to inform potential specifications for EHCs, test the specific prototypes, and collect data to answer a number of questions raised by the possible introduction of EHCs to vaccine cold chain systems.

Immunization Matters provides quarterly updates from PATH’s Center for Vaccine Innovation and Access (CVIA) on late-stage and licensed vaccines included in our portfolio as well as our work on health economics and optimization, operations research, and support to countries. It includes updates on our progress, partnerships, and specific activities.This is one of two newsletters published by CVIA. Moving the Needle covers CVIA’s vaccine development work.

Soil-transmitted helminths (STH) are parasitic intestinal worms that are controlled with mass drug administration in at-risk populations. The work described in this poster aims to develop a rapid, field-deployable, non-instrumented, magnetic bead-based protocol to extract STH egg DNA in stool, using Ascaris suum as model species, for use as a companion tool to recombinase polymerase amplification (RPA)-based diagnostics for STH.

Following the implementation of a successful study trial to evaluate mass drug administration (MDA), the next logical step is to transition to program mode. A modified MDA program has been developed based on evidence generated from the trial that is currently being implemented in southern Zambia.